New prognostic factors in melanoma: mRNA tumour markers
- 1 April 1998
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 34, 37-41
- https://doi.org/10.1016/s0959-8049(97)10163-0
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Immunophenotyping of melanomas for tyrosinase: implications for vaccine development.Proceedings of the National Academy of Sciences, 1995
- The molecular detection of circulating tumour cellsBritish Journal of Cancer, 1995
- A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.The Journal of Experimental Medicine, 1994
- Tumour cell detection in the bone marrow of breast cancer patients at primary therapy: results of a 3-year median follow-upBritish Journal of Cancer, 1994
- Pigmentation Genes: the Tyrosinase Gene Family and the pmel 17 Gene FamilyJournal of Investigative Dermatology, 1993
- Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patientsThe Lancet, 1992
- Bone marrow micrometastases in primary breast cancer: Prognostic significance after 6 years' follow-upEuropean Journal of Cancer and Clinical Oncology, 1991
- Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reactionThe Lancet, 1991
- Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases.Journal of Clinical Oncology, 1991
- Isolation and sequence of a cDNA clone for human tyrosinase that maps at the mouse c-albino locus.Proceedings of the National Academy of Sciences, 1987